Andrukhova M.P., Romaniuk A.M., Kudryavtsev Yu.M.
Department of Pathology
Medical Institute, Sumy State University, Ukraine
Toufik’s Medical Journal
Volume 1, Supplement 1, November 2021
Abstract from Biomedical Perspectives III
Introduction: Cancer of the prostate is a malignant new solution, as a result of the alveolar-cell disease. One of the topical problems of complicity is the new solution to the problem of death before the death of the fourth month in Ukraine. For the first time, 370 thousand copies of the malignant new establishment in front of the throat zone are diagnosed.
Aim: To investigate the frequency and stages of prostate cancer in Sumy region
Materials and methods During the survey, the history of prostate cancer patients in Sumy region for 2020 and the analysis of scientific sources using the scientific metric database of published databases Google Scholar were studied.
Results: In 2020, 168 people were registered in Sumy for prostate cancer. 29 patients were diagnosed with prostate cancer for the first time, which is 17.3%. Among the identified patients with stage I-II prostate cancer, 105 patients were diagnosed, which is 66.2%. Stage III – in 57 patients 13.3%. In 6 patients stage IV cancer was detected, which is 20.7%. In 2020, 4 men died, which is 2.3% of the total number of patients with prostate cancer
Conclusions: Thus, a malignant neoplasm of the prostate tends to grow. Due to the reduced screening examination and not pronounced symptoms of the disease, the growth of patients is constantly increasing. Timely examination and diagnosis of the risk group for prostate disease increases the overall quality of life and reduces the progression of prostate cancer.